Tucidinostat
- Generic Name
- Tucidinostat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H19FN4O2
- CAS Number
- 1616493-44-7
- Unique Ingredient Identifier
- 87CIC980Y0
- Indication
Investigated for use/treatment in cancer/tumors (unspecified).
- Associated Conditions
- -
- Associated Therapies
- -
Chidamide Plus R-CHOP in Elderly DLBCL
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 49
- Registration Number
- NCT02753647
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma
- First Posted Date
- 2016-04-11
- Last Posted Date
- 2020-04-01
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT02733380
- Locations
- 🇨🇳
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university, ZhengZhou, Henan, China
Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir
- First Posted Date
- 2015-08-03
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Tang-Du Hospital
- Target Recruit Count
- 13
- Registration Number
- NCT02513901
- Locations
- 🇨🇳
Department of Infectious Diseases, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China
Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer
- First Posted Date
- 2015-06-26
- Last Posted Date
- 2022-01-12
- Lead Sponsor
- Chipscreen Biosciences, Ltd.
- Target Recruit Count
- 365
- Registration Number
- NCT02482753
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Anhui Provincial Hospital, Hefei, Anhui, China
🇨🇳Zhejiang Cancer Hospital, Hangzhou, Jiangsu, China
Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-04-22
- Last Posted Date
- 2016-02-01
- Lead Sponsor
- Chipscreen Biosciences, Ltd.
- Target Recruit Count
- 124
- Registration Number
- NCT01836679
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳Beijing Chest Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Hebei Provincial Tumor Hospital, Shijiazhuang, Hebei, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.